Portal de Periódicos da CAPES

Inhaled nitric oxide does not improve systemic oxygenation after bidirectional superior cavopulmonary anastomosis

2004; Elsevier BV; Volume: 129; Issue: 1 Linguagem: Inglês

10.1016/j.jtcvs.2004.04.024

1097-685X

Ian Adatia, Andrew M. Atz, David Wessel,

Mechanical Circulatory Support Devices

Inhaled nitric oxide (NO) is a selective pulmonary vasodilator that decreases intrapulmonary shunt fraction.1Adatia I. Lillehei C. Arnold J.H. Thompson J.E. Palazzo R. Fackler J.C. et al.Inhaled nitric oxide in the treatment of postoperative graft dysfunction after lung transplantation.Ann Thorac Surg. 1994; 57: 1311-1318Abstract Full Text PDF PubMed Scopus (170) Google Scholar We sought to determine whether inhaled NO would ameliorate hypoxemia after bidirectional superior cavopulmonary anastomosis (BCPA). The research and ethics review board approved the study, and the parents of all children gave informed and written consent. We included patients with systemic oxygen saturations of 75% or less after BCPA without venous decompressing collaterals or pulmonary disease. Patients were mechanically ventilated and studied on the first postoperative day in the intensive care unit. From a stable baseline, patients received a 15-minute trial of inhaled NO (80 ppm).2Wessel D.L. Adatia I. Giglia T.M. Thompson J.E. Kulik T.J. Use of inhaled nitric oxide and acetylcholine in the evaluation of pulmonary hypertension and endothelial function after cardiopulmonary bypass Circulation. 1993; 88(part 1): 2128-2138Crossref Scopus (331) Google Scholar During the trial of inhaled NO, ventilator parameters and Fio2 were unchanged. In 5 patients, cyclic guanosine monophosphate (cGMP) levels were measured.2Wessel D.L. Adatia I. Giglia T.M. Thompson J.E. Kulik T.J. Use of inhaled nitric oxide and acetylcholine in the evaluation of pulmonary hypertension and endothelial function after cardiopulmonary bypass Circulation. 1993; 88(part 1): 2128-2138Crossref Scopus (331) Google Scholar One patient first received inhaled NO in the cardiac catheterization laboratory because of persistent hypoxemia after coil embolization of decompressing venous collaterals. This same patient was readmitted 7 months after BCPA with refractory hypoxemia as the result of respiratory syncytial viral pneumonitis and was treated with 10 ppm NO. A paired Student t test with a Bonferroni correction for 3 comparisons was used. The difference between cGMP levels was compared by the nonparametric Wilcoxon signed-rank test. We studied 26 patients with a median age of 0.5 years (range 0.2-13 years) and a weight of 6.5 kg (range 3-41 kg) who had undergone BCPA. All patients were undergoing the second stage of cardiac palliation for a functionally single ventricle. The diagnoses were hypoplastic left heart syndrome in 19 patients, tricuspid atresia with transposed great arteries with aortic obstruction in 3 patients, unbalanced atrioventricular canal defects in 2 patients, Ebstein anomaly of the tricuspid valve in 1 patient, and double-inlet left ventricle in 1 patient. The results of the trial of inhaled NO are displayed in TABLE 1, TABLE 2. There was no change in systemic oxygenation in response to inhaled NO. However, there was a significant decrease in superior vena caval pressure. Plasma cGMP increased significantly.TABLE 1Hemodynamic and blood gas response to inhaled nitric oxide after bidirectional superior cavopulmonary anastomosis (mean Fio2 0.76 ± 0.2)Mean SVCp (mm Hg)Mean CAp (mm Hg)TPG (mm Hg)Mean BP (mm Hg)SVC sat (%)Art sat (%)Art Pao2 (mm Hg)Art Paco2 (mm Hg)Art pHHR (beats/min)Pre-NO17 ± 37 ± 29 ± 565 ± 1133 ± 1163 ± 732 ± 438 ± 97.46 ± 0.08143 ± 21With NO15 ± 3*P = .002 compared with pre-NO.7 ± 27 ± 562 ± 934 ± 1265 ± 532 ± 438 ± 87.46 ± 0.07146 ± 20Post-NO16 ± 3†P = .013 compared with pre-NO.8 ± 28 ± 463 ± 1231 ± 764 ± 732 ± 438 ± 87.46 ± 0.06146 ± 18Art, Systemic arterial; BP, blood pressure; CAp, common atrial pressure; HR, heart rate; NO, nitric oxide; SVC, superior vena cava; SVCp, superior vena cava pressure; TPG, transpulmonary gradient. Values are mean ± SD.* P = .002 compared with pre-NO.† P = .013 compared with pre-NO. Open table in a new tab TABLE 2Cyclic guanosine monophosphate levels in response to inhaled nitric oxide after bidirectional superior cavopulmonary anastomosisSVC pmol/mL, median (range)Artery pmol/mL, median (range)Pre-NO11.2 (9.4-14.0)9.7 (9.2-13.2)With NO51.8 (30-124)*P = .04 pre-NO versus with NO.54.8 (36-128)*P = .04 pre-NO versus with NO.SVC, Superior vena cava; NO, nitric oxide.* P = .04 pre-NO versus with NO. Open table in a new tab Art, Systemic arterial; BP, blood pressure; CAp, common atrial pressure; HR, heart rate; NO, nitric oxide; SVC, superior vena cava; SVCp, superior vena cava pressure; TPG, transpulmonary gradient. Values are mean ± SD. SVC, Superior vena cava; NO, nitric oxide. One patient received a trial of inhaled NO during cardiac catheterization to coil decompressing venous collaterals. After deployment of coils, the aortic oxygen saturation increased from 50% to 62% with an Fio2 of 1.0. Inhaled NO changed aortic saturation minimally from 62% to 64%. Superior vena caval mean pressure decreased from 16 to 14 mm Hg. Pulmonary vein oxygen saturation and oxygen tension increased from 97% to 99% and 94 to 260 mm Hg, respectively. This patient was readmitted with respiratory syncytial viral pneumonitis, hypoxemia, and facial edema without cavopulmonary obstruction. The inhaled NO was administered at 10 ppm, systemic oxygen saturations increased from 48% to 87%, and transpulmonary gradient decreased from 12 to 4 mm Hg. Treatment was continued for 93 hours with gradual resolution of pneumonia. The mean hemoglobin concentration was 13.9 ± 2 g/dL, and the methemoglobin concentration was 0.6 ± 1.4 g/dL. Nitrogen dioxide levels ranged from less than 1 to 4 ppm. We found that inhaled NO does not improve systemic oxygenation after BCPA in the absence of intrapulmonary shunting. The decrease in superior vena caval pressure and increase in plasma cGMP indicate that sufficient NO was delivered to activate guanylate cyclase and cause vasodilation. This suggests that pulmonary vasoconstriction does not limit pulmonary blood flow or determine systemic oxygen saturations after BCPA. In 1 patient with pulmonary venous desaturation, inhaled NO enhanced ventilation perfusion matching with substantial improvement in oxygenation. Previous studies of the effect of inhaled NO after BCPA are equivocal. In 4 patients, oxygenation deteriorated when NO was withdrawn, and 5 patients demonstrated a 5% increase in systemic oxygen saturation.3Gamillscheg A. Zobel G. Urlesberger B. Berger J. Dacar D. Stein J.I. et al.Inhaled nitric oxide in patients with critical pulmonary perfusion after Fontan-type procedures and bidirectional Glenn anastomosis.J Thorac Cardiovasc Surg. 1997; 113: 435-442Abstract Full Text Full Text PDF PubMed Scopus (68) Google Scholar, 4Yahagi N. Kumon K. Tanigami H. Watanabe Y. Haruna M. Hayashi H. et al.Cardiac surgery and inhaled nitric oxide: indication and follow-up (2-4 years).Artif Organs. 1998; 22: 886-891Crossref PubMed Scopus (16) Google Scholar Clinical details are insufficient to determine whether these patients had pulmonary venous desaturation.3Gamillscheg A. Zobel G. Urlesberger B. Berger J. Dacar D. Stein J.I. et al.Inhaled nitric oxide in patients with critical pulmonary perfusion after Fontan-type procedures and bidirectional Glenn anastomosis.J Thorac Cardiovasc Surg. 1997; 113: 435-442Abstract Full Text Full Text PDF PubMed Scopus (68) Google Scholar, 4Yahagi N. Kumon K. Tanigami H. Watanabe Y. Haruna M. Hayashi H. et al.Cardiac surgery and inhaled nitric oxide: indication and follow-up (2-4 years).Artif Organs. 1998; 22: 886-891Crossref PubMed Scopus (16) Google Scholar In contrast, we showed in 26 patients that inhaled NO does not improve systemic oxygenation in the absence of pulmonary venous desaturation after BCPA. These observations suggest that cardiac output and cerebral blood flow after BCPA are more important determinants of oxygenation than pulmonary vascular resistance. Indeed, recent studies demonstrated that a strategy of permissive hypercapnia improves oxygenation after BCPA.5Bradley S.M. Simsic J.M. Mulvihill D.M. Hypoventilation improves oxygenation after bidirectional superior cavopulmonary connection J Thorac Cardiovasc Surg. 2003; 126: 1033-1039Abstract Full Text Full Text PDF PubMed Scopus (72) Google Scholar, 6Hoskote A, Li J, Hickey C, Erickson S, vanArsdell G, Stephens D, et al. The effects of carbon dioxide on oxygenation, systemic, cerebral and pulmonary vascular hemodynamics after the bidirectional superior cavopulmonary anastomosis. J Am Coll Cardiol. In press.Google Scholar Although we report a "negative study," it has important implications both for the additional insight provided into the unique physiology of BCPA and the therapeutic economics. Inhaled NO has been transformed from an inexpensive medical grade gas to a costly pharmaceutical grade gas. Therefore, the use of inhaled NO should be justified fiscally and therapeutically. Our study suggests that after BCPA, strategies that increase cardiac output and cerebral blood flow (eg, hypercapnia) are more likely to improve oxygenation than inhaled NO unless there is concomitant pulmonary venous desaturation.